Radefeldt, M.; Stellmacher-Kaiser, S.; Krake, S.; Kragl, B.; Lemke, S.; Beetz, C.; Bauer, P.; Junghanß, C.; Al-Ali, R.
Basic ctDNA Panel Promises Affordable Clinical Validity in Colon Cancer Patients but Not in Pancreas Cancer Patients. Life 2023, 13, 2274.
https://doi.org/10.3390/life13122274
AMA Style
Radefeldt M, Stellmacher-Kaiser S, Krake S, Kragl B, Lemke S, Beetz C, Bauer P, Junghanß C, Al-Ali R.
Basic ctDNA Panel Promises Affordable Clinical Validity in Colon Cancer Patients but Not in Pancreas Cancer Patients. Life. 2023; 13(12):2274.
https://doi.org/10.3390/life13122274
Chicago/Turabian Style
Radefeldt, Mandy, Silke Stellmacher-Kaiser, Susann Krake, Brigitte Kragl, Sabrina Lemke, Christian Beetz, Peter Bauer, Christian Junghanß, and Ruslan Al-Ali.
2023. "Basic ctDNA Panel Promises Affordable Clinical Validity in Colon Cancer Patients but Not in Pancreas Cancer Patients" Life 13, no. 12: 2274.
https://doi.org/10.3390/life13122274
APA Style
Radefeldt, M., Stellmacher-Kaiser, S., Krake, S., Kragl, B., Lemke, S., Beetz, C., Bauer, P., Junghanß, C., & Al-Ali, R.
(2023). Basic ctDNA Panel Promises Affordable Clinical Validity in Colon Cancer Patients but Not in Pancreas Cancer Patients. Life, 13(12), 2274.
https://doi.org/10.3390/life13122274